azacitidine has been researched along with bmn 673 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Baer, MR; Baylin, SB; Bentzen, SM; Duong, VH; Emadi, A; Kogan, AA; Lapidus, RG; Mi, T; Niyongere, S; O'Connell, CL; Rassool, FV; Youngblood, BA | 1 |
1 trial(s) available for azacitidine and bmn 673
Article | Year |
---|---|
Phase I Clinical Trial of DNA Methyltransferase Inhibitor Decitabine and PARP Inhibitor Talazoparib Combination Therapy in Relapsed/Refractory Acute Myeloid Leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Decitabine; DNA; Humans; Leukemia, Myeloid, Acute; Methyltransferases; Phthalazines; Poly(ADP-ribose) Polymerase Inhibitors | 2022 |